Inhaler Overuse in Children Sparks Call for Better Asthma Monitoring

A pioneering study currently underway at University Hospital Southampton is shining a much-needed spotlight on a critical issue in pediatric respiratory health: the dangerous reliance on reliever medications. Researchers are actively exploring whether enhanced asthma check-ups can effectively reduce the frequency of inhaler usage among young patients.

The stakes for pediatric health are remarkably high. Research indicates that children who use six or more blue reliever inhalers annually face a three to five times greater risk of suffering a severe asthma attack. While these blue inhalers are essential for treating immediate symptoms, they merely mask the underlying airway inflammation, leaving the root cause unmanaged and paving the way for further disease exacerbations.

To combat this growing healthcare crisis, the Southampton study aims to implement a new automated alert system designed to seamlessly notify general practitioners (GPs) whenever a child is prescribed an excessive number of inhalers. This crucial prompt will trigger an immediate medical review, empowering healthcare professionals to intervene early and help prevent future asthma attacks.

Innovative med-tech company Bedfont Scientific Limited has strongly welcomed the research initiative. For over 15 years, the company has supported asthma care with its NObreath Fractional exhaled Nitric Oxide (FeNO) device, which quickly and easily measures airway inflammation through a patient's exhaled breath. This test provides clinicians with the objective insight needed to confidently guide medication decisions, prevent over-reliance on blue inhalers, and reduce unnecessary prescriptions.

Despite FeNO testing being officially recommended as a first-line diagnostic tool in UK asthma guidelines, patient access across primary care remains highly inconsistent. Jason Smith, CEO of Bedfont, emphasized that the over-reliance on reliever medication is a well-recognized marker of uncontrolled asthma. He advocates that "greater investment and targeted funding are urgently needed to support the widespread adoption of FeNO technology in primary care," ultimately helping clinicians deliver earlier diagnoses and significantly reduce preventable harm to children.

---

🔖 Sources

Study on inhaler overuse highlights urgent need for better objective asthma monitoring

New study aims to reduce asthma inhaler overuse in children

---

Keywords: Inhaler Overuse in Children

Inhaler Overuse in Children

---